BSE Live
Nov 07, 16:01Prev. Close
891.65
Open Price
910.05
Bid Price (Qty.)
914.05 (100)
Offer Price (Qty.)
917.60 (10)
NSE Live
Nov 07, 15:30Prev. Close
890.50
Open Price
925.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
915.05 (11)
| Cash Flow of Alivus Life Sciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 654.13 | 631.29 | 628.61 | 564.93 | 470.94 | |
| Net CashFlow From Operating Activities | 391.52 | 413.52 | 313.40 | 597.59 | 388.11 | |
| Net Cash Used In Investing Activities | -615.65 | -116.48 | -154.15 | -122.23 | -68.73 | |
| Net Cash Used From Financing Activities | -6.23 | -279.44 | -387.59 | -78.80 | -213.78 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -230.35 | 17.59 | -228.33 | 396.56 | 105.60 | |
| Cash And Cash Equivalents Begin of Year | 301.41 | 283.82 | 512.16 | 115.60 | 10.00 | |
| Cash And Cash Equivalents End Of Year | 71.06 | 301.41 | 283.82 | 512.16 | 115.60 |
05.08.2025
Alivus Life Standalone June 2025 Net Sales at Rs 601.85 crore, up 2.25% Y-o-Y
25.10.2024
Glenmark Life Standalone September 2024 Net Sales at Rs 506.88 crore, down 14.86% Y-o-Y
26.07.2024
Glenmark Life Standalone June 2024 Net Sales at Rs 588.62 crore, up 1.76% Y-o-Y
26.04.2024
Glenmark Life Standalone March 2024 Net Sales at Rs 536.60 crore, down 13.64% Y-o-Y